Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RESTORE: An RCT to Evaluate the Efficacy of the Revi System

NCT: NCT06217328 · ACTIVE_NOT_RECRUITING

NCT IDNCT06217328
StatusACTIVE_NOT_RECRUITING
Start Date2024-02-24
Completion2027-02-28
SponsorBlueWind Medical (INDUSTRY)
First posted
Last updated

Brief Summary

The Revi System is indicated for the treatment of patients with symptoms of urgency incontinence alone or in combination with urinary urgency.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑